Variant report
Variant | esv3474100 |
---|---|
Chromosome Location | chr6:74932642-74933144 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529232802 | chr6:74932646-74932647 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76651353 | chr6:74932648-74932649 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112466851 | chr6:74932673-74932674 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371101302 | chr6:74932720-74932721 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376761372 | chr6:74932723-74932724 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114650935 | chr6:74932728-74932729 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552725816 | chr6:74932730-74932731 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192981884 | chr6:74932768-74932769 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116499038 | chr6:74932818-74932819 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556758331 | chr6:74932827-74932828 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185316438 | chr6:74932841-74932842 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148537916 | chr6:74932891-74932892 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144800536 | chr6:74932919-74932920 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553339689 | chr6:74933001-74933002 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571727210 | chr6:74933002-74933003 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568142534 | chr6:74933032-74933033 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9359072 | chr6:74933036-74933037 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs373860751 | chr6:74933054-74933055 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201617481 | chr6:74933072-74933073 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs199921457 | chr6:74933073-74933074 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188187513 | chr6:74933082-74933083 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557574218 | chr6:74933095-74933096 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2788966 | chr6:74933097-74933098 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs543247656 | chr6:74933100-74933101 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561946932 | chr6:74933116-74933117 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552883100 | chr6:74933135-74933136 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 17437010 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:74932200-74933200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr6:74932200-74933400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr6:74932200-74933600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr6:74932400-74932800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr6:74932400-74933000 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr6:74932400-74933000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr6:74932400-74933000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:74932400-74933000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr6:74932400-74933000 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
10 | chr6:74932400-74933200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
11 | chr6:74932600-74933000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr6:74932600-74933000 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr6:74932600-74933200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr6:74932800-74933000 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
15 | chr6:74932800-74933200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr6:74932800-74933400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
17 | chr6:74933000-74933200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr6:74933000-74933200 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |